-
India continues slow, steady climb on US Chamber International IP Index
expresspharma
March 25, 2021
The US Chamber of Commerce Global Innovation Policy Center (GIPC) released its ninth annual International IP Index Recovery Through Ingenuity highlighting the extraordinary role of intellectual property (IP) rights in discovering and delivering ...
-
Bayer wins ‘Best Employer in India’ Award from Kincentric
expresspharma
March 19, 2021
Bayer has been named by Kincentric as one of India’s “Best Employers” for 2020. This is the fourth consecutive year since 2017 that Bayer has bagged this award.
-
India asks States to manage immunisation drives better
expresspharma
March 19, 2021
About 6.5 per cent of coronavirus vaccine doses in India are going to waste, health officials said, urging states to manage their immunisation drives better to optimise the use of what one called “this elixir-like precious commodity”.
-
India’s reputation as pharmacy of world reinforced: Jaishankar
expresspharma
March 18, 2021
Making a statement in the Rajya Sabha on ‘Vaccine Maitri’ initiative, he said that India has supplied 'Made-in-India' vaccine to 72 nations.
-
Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio
expresspharma
March 15, 2021
Samir Vyas, Country Manager, Agilent India says India companies are now moving into the global biopharma market and gives his views on the role of policies like Make in India/Atmanirbhar Bharat, a more vigilant US FDA after the sartan episode and ...
-
A large randomized clinical trial shows significant reduction in urinary tract infections
prnasia
March 12, 2021
A recently published, randomized, controlled multicenter study in India shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard ...
-
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports
expresspharma
March 11, 2021
Pfizer has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
-
Quad nations meet to declare financing to enhance India vaccine output – US official
expresspharma
March 10, 2021
The aim of the initiative by the Quad, which groups the US, India, Japan and Australia, would be to reduce manufacturing backlogs, speed vaccination, and defeat some coronavirus mutations.
-
India’s Covaxin® 81 percent effective against COVID-19
europeanpharmaceuticalreview
March 09, 2021
An interim analysis reveals the Covaxin® (BBV152) vaccine was relatively safe and 81 percent effective in preventing symptomatic COVID-19.
-
Launch of generic oncology medications to improve treatment access in India
europeanpharmaceuticalreview
March 04, 2021
GlobalData suggests the recent approval of new generics in oncology should enhance access and adherence to cancer treatment by reducing costs borne by patients.